【结 构 式】 |
【药物名称】VUF-5087 【化学名称】6-Chloro-4-oxo-2-[3-[2(E)-(2-quinolyl)vinyl]phenyl]-4H-1-benzopyran-8-carboxylic acid 【CA登记号】 【 分 子 式 】C27H16ClNO4 【 分 子 量 】453.88587 |
【开发单位】Kowa; Vrije Univ., Amsterdam (NL) 【药理作用】RESPIRATORY DRUGS, ASTHMA THERAPY |
合成路线1
The intermediate acetophenone (III) was prepared from 5-chlorosalicylic acid (I) by O-acetylation with acetic anhydride and a catalytic amount of sulfuric acid, followed by Fries rearrangement of the resulting acetate (II) on heating with aluminum chloride. Condensation of 2-methylquinoline (IV) with an excess of 1,3-benzene dicarboxaldehyde (V) in a refluxing mixture of acetic anhydride and xylene provided aldehyde (VI), which was then condensed with acetophenone (III) by treatment with KOH in a mixture of ethanol and tetrahydrofuran to give chalcone (VII). Finally, oxidative ring closure by refluxing with selenium dioxide in dioxan yielded the desired flavone.
【1】 Zwaagstra, M. E.; et al.; Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists. J Med Chem 1998, 41, 9, 1428. |
【2】 Zwaagstra, M.E.; et al.; Synthesis and structure - activity relationships of carboxylated chalcones: A novel series of CysLT1 (LTD4) receptor antagonists. J Med Chem 1997, 40, 7, 1075. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 13895 | 5-Chloro-2-hydroxybenzoic acid; 5-Chlorosalicylic acid | 321-14-2 | C7H5ClO3 | 详情 | 详情 |
(II) | 18865 | 2-(acetoxy)-5-chlorobenzoic acid | C9H7ClO4 | 详情 | 详情 | |
(III) | 18866 | 3-acetyl-5-chloro-2-hydroxybenzoic acid | C9H7ClO4 | 详情 | 详情 | |
(IV) | 13161 | Quinaldine; 2-Methylquinoline | 91-63-4 | C10H9N | 详情 | 详情 |
(V) | 18868 | isophthalaldehyde | 626-19-7 | C8H6O2 | 详情 | 详情 |
(VI) | 18869 | 3-[(E)-2-(2-quinolinyl)ethenyl]benzaldehyde | C18H13NO | 详情 | 详情 | |
(VII) | 18870 | 5-chloro-2-hydroxy-3-((E)-3-[3-[(E)-2-(2-quinolinyl)ethenyl]phenyl]-2-propenoyl)benzoic acid | C27H18ClNO4 | 详情 | 详情 |